Opendata, web and dolomites

In-Cytes SIGNED

IN-CYTES A HIGH-DENSITY MICROELECTRODE ARRAY PLATFORM FOR LARGE-SCALE INTRACELLULAR FUNCTIONAL ASSAYS

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 In-Cytes project word cloud

Explore the words cloud of the In-Cytes project. It provides you a very rough idea of what is the project "In-Cytes" about.

opportunity    innovation    biosystems    small    limited    academic    lacking    cytes    alzheimer    nerve    pharmacy    parkinson    neural    unknown    resolution    bio    mxw    throughput    preclinical    budget    overcome    maxwell    combining    business    ag    direct    innovative    minimum    quantifying    brand    technologies    cells    bioassays    barriers    spatial    continue    relatively    connectivity    neuroscience    engineering    initial    neurodegenerative    career    grant    neurons    enterprise    software    electrophysiological    skills    indirect    envisaged    industrial    company    basic    physiology    hardware    thousands    compete    platforms    expertise    drug    brain    associate    swiss    salary    drugs    radically    cure    public    data    expert    physiological    featuring    interference    disorders    contrast    multidisciplinary    visibility    employment    microfabrication    first    larger    companies    discovery    intracellular    poor    estimate    recruitment    either    start    prototype    platform    electrophysiology    diseases    perceived    turn   

Project "In-Cytes" data sheet

The following table provides information about the project.

Coordinator
MAXWELL BIOSYSTEMS AG 

Organization address
address: ALBISRIEDERSTRASSE 253
city: ZURICH
postcode: 8047
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Switzerland [CH]
 Total cost 135˙500 €
 EC max contribution 135˙500 € (100%)
 Programme 1. H2020-EU.2.3.2.2. (Enhancing the innovation capacity of SMEs)
 Code Call H2020-INNOSUP-2019-02
 Funding Scheme CSA
 Starting year 2019
 Duration (year-month-day) from 2019-10-15   to  2020-10-14

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    MAXWELL BIOSYSTEMS AG CH (ZURICH) coordinator 135˙500.00

Map

 Project objective

MaxWell Biosystems AG (MxW) is a Swiss public limited company (AG) who developed electrophysiological platforms (hardware-software-bioassays) for basic research and drug testing on nerve cells. MxW’s aim is to develop In-Cytes, a radically innovative electrophysiology platform to assess neural connectivity for preclinical drug discovery for brain diseases. In contrast to the state-of-the-art technologies for quantifying neural connectivity, which either estimate indirect connectivity or feature poor spatial resolution, In-Cytes can measure physiological direct neural intracellular connectivity among thousands of neurons. This directly addresses the industrial need in pharmacy for neural connectivity bioassays, featuring high-throughput and minimum interference with neurons’ physiology for the development of effective drugs to cure neurodegenerative disorders, such as Alzheimer’s and Parkinson’s diseases.

The proposed recruitment of an Innovation Associate will have significant impact on the business opportunities of MxW by bringing in lacking expertise for the development of In-Cytes. The envisaged grant will help to overcome the recruitment barriers of being a relatively unknown, small start-up enterprise that cannot compete with larger companies due to limited visibility, brand awareness, (perceived) career opportunities, salary and recruitment budget.

The development of In-Cytes requires the employment of an academic expert with a multidisciplinary set of skills combining knowledge in neuroscience, microfabrication and data analysis. In turn, the innovation associate will have the opportunity to become an expert in the emerging field of bio-engineering. It is in the interest of the company to continue the employment after the initial year in order to develop the first prototype of In-Cytes into an industrial end product.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "IN-CYTES" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "IN-CYTES" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.2.3.2.2.)

EENinnoSMES4 (2020)

EEN Anatolia supports to increase the innovation management capacities of SMEs

Read More  

RailActivation (2019)

ACTIVATING INCLUSIVE GROWTH IN RAILWAY SMES BY WORKPLACE INNOVATION

Read More  

Peer2Scale-Health (2019)

Peer2Scale-Health: Peer-learning action to improve innovation support to health SMEs in their scale-up process

Read More  
lastchecktime (2021-05-10 4:30:40) correctly updated